Search results
Showing 271 to 285 of 1003 results for public health medicine & health
Awaiting development Reference number: GID-TA10833 Expected publication date: TBC
Awaiting development Reference number: GID-TA11691 Expected publication date: TBC
This guideline covers managing hip fracture in adults. It aims to improve care from the time people aged 18 and over are admitted to hospital through to when they return to the community. Recommendations emphasise the importance of early surgery and coordinating care through a multidisciplinary Hip Fracture Programme to help people recover faster and regain their mobility.
Care and support of people growing older with learning disabilities (NG96)
This guideline covers care and support for adults with learning disabilities as they grow older. It covers identifying changing needs, planning for the future, and delivering services including health, social care and housing. It aims to support people to access the services they need as they get older.
This quality standard covers the clinical assessment and management of depression in adults aged 18 and over. It describes high-quality care in priority areas for improvement.
View quality statements for QS8Show all sections
Sections for QS8
- Quality statements
- Quality statement 1: Assessment
- Quality statement 2: Discussing treatment options
- Quality statement 3: Preventing relapse
- Quality statement 4: Stopping antidepressants
- Quality statement 5: Access to services for adults from minority ethnic backgrounds
- Update information
- About this quality standard
Our guidance is developed by independent committees, including professionals and lay members, and consulted on by stakeholders.
Tiratricol for treating Allan–Herndon–Dudley syndrome [ID6217]
Awaiting development Reference number: GID-TA11192 Expected publication date: TBC
Eneboparatide for treating chronic hypoparathyroidism [TSID12145]
Awaiting development Reference number: GID-TA11713 Expected publication date: TBC
Edaravone for treating amyotrophic lateral sclerosis [TSID11869]
Awaiting development Reference number: GID-TA11362 Expected publication date: TBC
Awaiting development Reference number: GID-TA11059 Expected publication date: TBC
WP1048 for treating grass pollen allergy in people aged 18 to 60 [TSID10467]
Awaiting development Reference number: GID-TA11305 Expected publication date: TBC
Awaiting development Reference number: GID-TA11271 Expected publication date: TBC
Nedosiran treating primary hyperoxaluria type 1 in people 6 years and over [TSID11777]
Awaiting development Reference number: GID-TA11292 Expected publication date: TBC
Awaiting development Reference number: GID-TA11150 Expected publication date: TBC
Gantenerumab for treating early Alzheimer's disease [TSID10668]
Awaiting development Reference number: GID-TA11072 Expected publication date: TBC